Groupe Hospitalier Pellegrin - Hôpital Pellegrin

Bordeaux, Gironde 33076

0 studies enrolling now · 11 studies all time

What they study most

Alzheimer's Disease, Atypical Parkinsonism, Brain Contusion, Brain Edema, Chronic Inflammatory Demyelinating Polyradiculoneuropathy, Lupus Erythematosus, Systemic, Neurodegenerative Diseases, PSP, Progressive Supranuclear Palsy, Refractory Generalized Myasthenia Gravis, Stroke, Acute

Studies at this site

• AMX0035 and Progressive Supranuclear Palsy — Completed
• A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus — Running, not enrolling
• A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease — Stopped early
• A Study to Evaluate Safety and Tolerability of Aducanumab in Participants With Alzheimer's Disease Who Had Previously Participated in the Aducanumab Studies 221AD103, 221AD301, 221AD302 and 221AD205 — Stopped early
• A Study to Evaluate the Efficacy and Safety of BIIB093 in Participants With Brain Contusion — Stopped early
• Phase 3 Study to Evaluate the Efficacy and Safety of Intravenous BIIB093 (Glibenclamide) for Severe Cerebral Edema Following Large Hemispheric Infarction — Stopped early
• Long-Term Tolerability and Safety of HYQVIA/HyQvia in CIDP — Completed
• A Study of HyQvia and Gammagard Liquid (Kiovig) in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP) — Completed
• Phase 2 Study of BIIB092 in Participants With Early Alzheimer's Disease — Stopped early
• 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease — Stopped early
• Safety and Efficacy of Eculizumab in Refractory Generalized Myasthenia Gravis (REGAIN Study) — Completed